USANA Health Sciences, Inc. (NYSE:USNA) shares reached a new 52-week low during trading on Tuesday . The company traded as low as $60.96 and last traded at $61.35, with a volume of 4772 shares traded. The stock had previously closed at $62.03.
A number of analysts have commented on USNA shares. ValuEngine raised shares of Westpac Banking from a “sell” rating to a “hold” rating in a report on Wednesday, May 22nd. Sidoti lowered shares of OMNOVA Solutions from a “buy” rating to a “neutral” rating and set a $10.00 target price for the company. in a report on Wednesday, July 3rd. Pivotal Research reissued a “buy” rating and issued a $75.00 price target on shares of USANA Health Sciences in a report on Wednesday, July 3rd. Finally, Tigress Financial assumed coverage on shares of USANA Health Sciences in a report on Tuesday, April 16th. They issued a “buy” rating for the company.
The stock has a market capitalization of $1.44 billion, a P/E ratio of 11.42 and a beta of 0.51. The company’s fifty day simple moving average is $72.03.
Several hedge funds have recently made changes to their positions in USNA. Norges Bank acquired a new position in shares of USANA Health Sciences in the 4th quarter valued at $35,531,000. MERIAN GLOBAL INVESTORS UK Ltd grew its holdings in shares of USANA Health Sciences by 54.1% in the 1st quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 363,410 shares of the company’s stock valued at $30,479,000 after buying an additional 127,543 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of USANA Health Sciences by 108.1% in the 1st quarter. JPMorgan Chase & Co. now owns 111,904 shares of the company’s stock valued at $9,385,000 after buying an additional 58,121 shares during the period. Marshall Wace LLP bought a new stake in USANA Health Sciences in the 1st quarter valued at $3,525,000. Finally, Nordea Investment Management AB lifted its position in USANA Health Sciences by 124.0% in the 4th quarter. Nordea Investment Management AB now owns 62,315 shares of the company’s stock valued at $7,337,000 after acquiring an additional 34,500 shares in the last quarter. 59.70% of the stock is owned by institutional investors.
USANA Health Sciences Company Profile (NYSE:USNA)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
See Also: Stop Order
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.